0001567619-20-004735.txt : 20200224
0001567619-20-004735.hdr.sgml : 20200224
20200224175247
ACCESSION NUMBER: 0001567619-20-004735
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200220
FILED AS OF DATE: 20200224
DATE AS OF CHANGE: 20200224
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: AYERS JONATHAN W
CENTRAL INDEX KEY: 0001184149
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19271
FILM NUMBER: 20645953
MAIL ADDRESS:
STREET 1: IDEXX LABORATORIES, INC.
STREET 2: ONE IDEXX DRIVE
CITY: WESTBROOK
STATE: ME
ZIP: 04092
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IDEXX LABORATORIES INC /DE
CENTRAL INDEX KEY: 0000874716
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 010393723
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE IDEXX DRIVE
CITY: WESTBROOK
STATE: ME
ZIP: 04092-2041
BUSINESS PHONE: 2075560300
MAIL ADDRESS:
STREET 1: ONE IDEXX DRIVE
CITY: WESTBROOK
STATE: ME
ZIP: 04092-2041
FORMER COMPANY:
FORMER CONFORMED NAME: IDEXX CORP / DE
DATE OF NAME CHANGE: 19600201
4
1
doc1.xml
FORM 4
X0306
4
2020-02-20
0
0000874716
IDEXX LABORATORIES INC /DE
IDXX
0001184149
AYERS JONATHAN W
ONE IDEXX DRIVE
WESTBROOK
ME
04092
1
0
0
0
Common Stock
2020-02-20
4
M
0
23000
62
A
832861
D
Common Stock
2020-02-20
4
S
0
4573
280.3420
D
828288
D
Common Stock
2020-02-20
4
S
0
400
281.30
D
827888
D
Common Stock
2020-02-20
4
S
0
1000
282.69
D
826888
D
Common Stock
2020-02-20
4
S
0
1400
284.0440
D
825488
D
Common Stock
2020-02-20
4
S
0
8375
285.9800
D
817113
D
Common Stock
2020-02-20
4
S
0
4600
286.8140
D
812513
D
Common Stock
2020-02-20
4
S
0
1424
287.7160
D
811089
D
Common Stock
2020-02-20
4
S
0
300
288.6670
D
810789
D
Common Stock
2020-02-20
4
S
0
928
290.2366
D
809861
D
Common Stock
2020-02-21
5
G
0
650
0
D
809211
D
Common Stock
2020-02-21
4
S
0
400
280.3988
D
137600
I
by Ayers Family Trust
Non-Qualified Stock Option (right-to-buy)
62
2020-02-20
4
M
0
23000
D
2024-02-13
Common Stock
23000
66070
D
Represents the weighted average price of the shares sold ranging from a low of $280.04 to a high of $281.00 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $281.16 to a high of $281.72 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $282.30 to a high of $283.08 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $283.54 to a high of 284.48 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $285.51 to a high of $286.42 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $286.52 to a high of $287.51 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $287.54 to a high of $288.53 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $288.60 to a high of $288.71 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $290.07 to a high of $290.39 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Grant of option to buy 44,535 shares of IDEXX Laboratories, Inc. common stock that became exercisable in five equal annual installments beginning on February 14, 2015 without giving effect to the 2-for-1 stock split of IDEXX Laboratories, Inc. common stock that occurred on June 15, 2015 (the "Stock Split"). The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split.
Not applicable.
/s/ Lily J. Lu, Attorney-in-Fact for Jonathan W. Ayers
2020-02-24